B3PM77 AF NFT

DNA-directed RNA polymerase subunit beta'

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeicfxdznu5pv2rlgwwth25qisrm73hk3ofpehn4gpw6r44m3mzo64e/metadata.json
IPFS of structure file: 
bafybeie73l6vt6rb4j6xuzsgwpuv6w2wgeswak5kwgzi7rul5qnsoqp2ai/AF-B3PM77-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xF531FAB16aa2afbeEDcbcAf6Fe967B65FcbA2B18
First NFT owner address (bech32): 
genesis175cl4vt252hmamwtetm0a9nmvh7t52cckhwnsr
Current NFT ID #388488 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
388488
Accession (UniProt):
B3PM77
Name::
DNA-directed RNA polymerase subunit beta'
Experimental Method:
Predicted structure
Sequence source:
Mycoplasma arthritidis (strain 158L3-1)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B3PM77 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B3PM77|RPOC_MYCA5 DNA-directed RNA polymerase subunit beta' OS=Mycoplasma arthritidis (strain 158L3-1) OX=243272 GN=rpoC PE=3 SV=1 MKKSRKYATLDSDKIAKISLALATPDDVESWSHGEVTKPETINYKSYKPERGGLFDEIIFGPMIDYRCPICGHKYKKINEGSFCSKTELCKQEKVEILPKISRRNHMGHIKLNSPVVHFWFFKVDHSIIFKLLDLTVAGRPNTEPVRRIDLENLIYYKSHIVLESGGIKALPKNLIIDINVAAVIYKDALEELITRFEPGTEDYEDIRETLDNLIEKASSKIGQDYGIDFYELNEVIEHYSEAKIGTGAQAIEYLLKNLDLQKEKELVSAKIKKINDEEIMSGAKIASTSRQTREKLYKRLQVINAFIESKQEPTSMLIYNLPVIPADLRPLIQLDGGRHSTSDINELYRRVIIRNNRLKQWQEKDAPTLVIQNELRMIQEAVDALIDNARRSPNPVLSKDNRPFKSISDALTGKKGRFRQNLLGKRVDYSGRSVIVVGPNLKMHQCGIPREMAAKLFEPWIIHRLIEKEVATTIKNAKKMLEDQNPVIWPHIAEVIKGRLVLLNRAPTLHRLSIQAFEPVLVRGKAIRLHPLVCTPFNADFDGDQMAVHVPISERALLESRELMLANKNILGTKDGEPIINPSQDMILGIYYLTIEEPGALGEGRIFDNYEHMIRAYEAKKVSLHARVALPIEEVKNSKIKAFASRESQRYIISTVGKFIFNNIFPKSFPFIFDNKVTEATSLEQYSEKVNKYIIPAGTNVIEHIKMELPVLDAFNKKNIAKIIRYVFDKYVAALTLQDVAGVIDQLNDVPLSNIVLNYLNLKTYDDRKVDQEHAIILAALTRSATEKTKARSQRHIEGLEVPLNAEEKAEILDDVWFRYTNMVASILDDIKDLGFKYSSLSGITFAISDILETDKKPEYIAEGDAYIAQLKQYYNDGLISDDDRYSLTIKKWTDIKAKVQGELQQIIKENPRNPIITMINSGARGNISNYVQLAGMRGLMANNTKSTRADVKNERVVRSTVEIPVKSSFIEGLTAFEFYSSTHGTRKGATDTALNTAKSGYLTRRLVDVAQNIVVRKENCGSDYGHIVRDIVDTKNGQIIVPLKERIIGRYANKPIIGEKTKQELAKRNTLITDKLAQKIIDEGVKEVEIRSVLGCNTKNGVCKMCFGKDLATNRVVNIGEAVGIIAAQSIGEPGTQLTMRVFHTGGVAGAEDITGGFPRLIELIDAHEQPWGRPAVISPYEGEIVEDLVEDKNVNSHLLTIKVVNSKKETVNKKVHVYTTKKLRVKVGDHVKVGQKLSEGPVIVKELLELTDTITVQNYLLKEIQKIYRIQGIAISDKYIEIIIRQMMSKIVIHDPGDSKFFAGAIVDIFDYQEENATLLSQRKRPAFGKVVIKGAKQVPLLSDSFLAAASYQETSKILVHAAISSRSDSLSGLKENIIVGKKIPAGTALYPFESHSKYDIRPSIDYFRKPELETSDSEFIPVDLESYHQELEDEQQQIIEVDDSDISVEDEENDFYENED